Search Results - "Sini, Patrizia"
-
1
Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase inhibitor AZD8055 induces autophagy and cell death in cancer cells
Published in Autophagy (16-05-2010)“…mTOR is a major biological switch, coordinating an adequate response to changes in energy uptake (amino acids, glucose), growth signals (hormones, growth…”
Get full text
Journal Article -
2
The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression
Published in Molecular cancer therapeutics (01-06-2015)“…Resistance to BRAF inhibitors is a major clinical problem. Here, we evaluate BI-847325, an ATP-competitive inhibitor of MEK and Aurora kinases, in…”
Get full text
Journal Article -
3
mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor
Published in Clinical cancer research (01-03-2009)“…Purpose: Comparison of the antiangiogenic/vascular properties of the oral mammalian target of rapamycin (mTOR) inhibitor RAD001 (everolimus) and the vascular…”
Get full text
Journal Article -
4
Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways
Published in Biochemical and biophysical research communications (28-08-2009)“…Untangling the signaling pathways involved in endothelial cell biology is of central interest for the development of antiangiogenesis based therapies. Here we…”
Get full text
Journal Article -
5
Inhibition of p53-MDM2 binding reduces senescent cell abundance and improves the adaptive responses of skeletal muscle from aged mice
Published in GeroScience (01-04-2024)“…Skeletal muscle adaptation to external stimuli, such as regeneration following injury and hypertrophy in response to resistance exercise, are blunted with…”
Get full text
Journal Article -
6
Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity
Published in Molecular cancer therapeutics (01-03-2008)“…M30 and M65 are ELISAs that detect different circulating forms of cytokeratin 18. Using the aurora kinase inhibitor AZD1152 and the SW620 human colon cancer…”
Get full text
Journal Article -
7
The Antitumor and Antiangiogenic Activity of Vascular Endothelial Growth Factor Receptor Inhibition Is Potentiated by ErbB1 Blockade
Published in Clinical cancer research (15-06-2005)“…Purpose: Receptor tyrosine kinases of the ErbB family play important roles in the control of tumor growth. Vascular endothelial growth factor (VEGF) stimulates…”
Get full text
Journal Article -
8
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
Published in Cancer research (Chicago, Ill.) (2010)“…The mammalian target of rapamycin (mTOR) kinase forms two multiprotein complexes, mTORC1 and mTORC2, which regulate cell growth, cell survival, and autophagy…”
Get full text
Journal Article -
9
Abstract 703: A novel ATP-competitive MEK/Aurora kinase inhibitor BI-847325 reverses acquired BRAF inhibitor resistance through suppression of Mcl-1 and inhibition of MEK expression
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract BACKGROUND: BRAF/MEK inhibitors have shown promising levels of response in melanomas harboring the BRAF V600E mutation, however responses tend to be…”
Get full text
Journal Article -
10
Heterogeneous Profile of ROR1 Protein Expression across Tumor Types
Published in Cancers (15-05-2024)“…The Wnt receptor ROR1 has generated increased interest as a cancer therapeutic target. Research on several therapeutic approaches involving this receptor is…”
Get full text
Journal Article -
11
Pharmacological Profile of BI 847325, an Orally Bioavailable, ATP-Competitive Inhibitor of MEK and Aurora Kinases
Published in Molecular cancer therapeutics (01-10-2016)“…Although the MAPK pathway is frequently deregulated in cancer, inhibitors targeting RAF or MEK have so far shown clinical activity only in BRAF- and…”
Get full text
Journal Article -
12
Abstract LB003: BI 907828: A highly potent MDM2-p53 antagonist suitable for intermittent dose schedules
Published in Cancer research (Chicago, Ill.) (14-04-2023)“…Abstract The E3 ligase MDM2 controls the tumor suppressor function of p53, which is encoded by the TP53gene. Compounds designed to bind to MDM2 preventing its…”
Get full text
Journal Article -
13
Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation
Published in Nature cell biology (01-03-2004)“…The non-receptor tyrosine kinase Abl participates in receptor tyrosine kinase (RTK)-induced actin cytoskeleton remodelling, a signalling pathway in which the…”
Get full text
Journal Article -
14
Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
Published in Cancer research (Chicago, Ill.) (01-03-2008)“…Vascular endothelial growth factor receptors (VEGFR) have important roles in cancer, affecting blood and lymphatic vessel functionality as well as tumor cells…”
Get full text
Journal Article -
15
Abstract 1919: Pharmacological characterization of BI 847325, a dual inhibitor of MEK and Aurora kinases
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract The RAS-dependent MAP kinase signaling pathway plays an important role in the regulation of cell proliferation and survival. RAS genes are frequently…”
Get full text
Journal Article -
16
Inhibition of Aurora-B kinase activity confers antitumor efficacy in preclinical mouse models of early and advanced gastrointestinal neoplasia
Published in International journal of oncology (01-10-2012)“…The Aurora family of kinases, play a fundamental role in cell division and are overexpressed in several cancers including colon. The activity of…”
Get full text
Journal Article -
17
An Effector Region in Eps8 Is Responsible for the Activation of the Rac-Specific GEF Activity of Sos-1 and for the Proper Localization of the Rac-Based Actin-Polymerizing Machine
Published in The Journal of cell biology (03-09-2001)“…Genetic and biochemical evidence demonstrated that Eps8 is involved in the routing of signals from Ras to Rac. This is achieved through the formation of a…”
Get full text
Journal Article -
18
Role of decorin on in vitro fibrillogenesis of type I collagen
Published in Glycoconjugate journal (01-11-1997)“…Tendon and corneal decorins are differently iduronated dermatan sulphate/proteoglycan (DS/PG) and the biochemical parameter that differentiates type I…”
Get full text
Journal Article -
19
Interaction of decorin with CNBr peptides from collagens I and II. Evidence for multiple binding sites and essential lysyl residues in collagen
Published in European journal of biochemistry (01-03-2002)“…Decorin is a small leucine-rich chondroitin/dermatan sulfate proteoglycan reported to interact with fibrillar collagens through its protein core and to…”
Get full text
Journal Article -
20
Interaction of decorin with CNBr peptides from collagens I and II
Published in European journal of biochemistry (01-03-2002)“…Decorin is a small leucine‐rich chondroitin/dermatan sulfate proteoglycan reported to interact with fibrillar collagens through its protein core and to…”
Get full text
Journal Article